Nephrogen, Inc.

Pharmaceutical preparations containing viral vectors for drug delivery consisting of compounds comprised of proteins in the form of capsids that facilitate the delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of viral capsids, viral and non viral vectors, and biodegradeable protein capsids that facilitate the delivery of pharmaceutical preparations; Pharmaceutical preparations for the treatment of kidney disease and genetic diseases disease; Development of pharmaceutical preparations and medicines; Research and development services in the field of pharmaceutical preparations; Development of new technology for others in the field of viral vector-based gene therapy and genomic medicines to treat kidney diseases as treatment

Development of new technology for others in the field of therapeutics, medical devices, pharmaceuticals, and lab equipment for the treatment of kidney disease, cancer, diabetes, and heart disease in patients; Development of new technology for others in the field of therapeutics for the treatment of kidney disease, cancer, diabetes, and heart disease in patients